{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:58:40Z","timestamp":1790787520770,"version":"4.1.0"},"reference-count":140,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T00:00:00Z","timestamp":1599350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Societe Francophone Nephrologie, Dialyse et Th\u00e9rapeutique","award":["01"],"award-info":[{"award-number":["01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Chronic kidney disease (CKD) is a global health problem characterized by progressive kidney failure due to uremic toxicity and the complications that arise from it. Anemia consecutive to CKD is one of its most common complications affecting nearly all patients with end-stage renal disease. Anemia is a potential cause of cardiovascular disease, faster deterioration of renal failure and mortality. Erythropoietin (produced by the kidney) and iron (provided from recycled senescent red cells) deficiencies are the main reasons that contribute to CKD-associated anemia. Indeed, accumulation of uremic toxins in blood impairs erythropoietin synthesis, compromising the growth and differentiation of red blood cells in the bone marrow, leading to a subsequent impairment of erythropoiesis. In this review, we mainly focus on the most representative uremic toxins and their effects on the molecular mechanisms underlying anemia of CKD that have been studied so far. Understanding molecular mechanisms leading to anemia due to uremic toxins could lead to the development of new treatments that will specifically target the pathophysiologic processes of anemia consecutive to CKD, such as the newly marketed erythropoiesis-stimulating agents.<\/jats:p>","DOI":"10.3390\/cells9092039","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T23:12:49Z","timestamp":1599433969000},"page":"2039","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review"],"prefix":"10.3390","volume":"9","author":[{"given":"Eya","family":"Hamza","sequence":"first","affiliation":[{"name":"HEMATIM UR 4666, C.U.R.S, Universit\u00e9 de Picardie Jules Verne, CEDEX 1, 80025 Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-8480","authenticated-orcid":false,"given":"Laurent","family":"Metzinger","sequence":"additional","affiliation":[{"name":"HEMATIM UR 4666, C.U.R.S, Universit\u00e9 de Picardie Jules Verne, CEDEX 1, 80025 Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1718-5083","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Metzinger-Le Meuth","sequence":"additional","affiliation":[{"name":"HEMATIM UR 4666, C.U.R.S, Universit\u00e9 de Picardie Jules Verne, CEDEX 1, 80025 Amiens, France"},{"name":"INSERM UMRS 1148, Laboratory for Vascular Translational Science (LVTS), UFR SMBH, Universit\u00e9 Sorbonne Paris Nord, CEDEX, 93017 Bobigny, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ndt\/gfg080","article-title":"Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity","volume":"18","author":"Stam","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","article-title":"The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair","volume":"65","author":"Dou","year":"2004","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1046\/j.1523-1755.63.s84.43.x","article-title":"New insights in uremic toxins","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1681\/ASN.2007121377","article-title":"A Bench to Bedside View of Uremic Toxins","volume":"19","author":"Vanholder","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1525-139X.2005.18313.x","article-title":"Reviews: Uremic Toxins: A New Focus on an Old Subject","volume":"18","author":"Yavuz","year":"2005","journal-title":"Semin. Dial."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and Pathologic Concentrations of Uremic Toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11255-012-0258-1","article-title":"An update on uremic toxins","volume":"45","author":"Neirynck","year":"2012","journal-title":"Int. Urol. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000369817","article-title":"Uremic Toxins and Their Effects on Multiple Organ Systems","volume":"128","year":"2014","journal-title":"Nephron Clin. Pr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1046\/j.1523-1755.2001.59780067.x","article-title":"Role of uremic toxins in exacerbating anemia in renal failure","volume":"59","author":"MacDougall","year":"2001","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ki.1993.327","article-title":"Molecular biology of erythropoietin","volume":"44","author":"Ratcliffe","year":"1993","journal-title":"Kidney Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1681\/ASN.V132504","article-title":"Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey","volume":"13","author":"Hsu","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.semnephrol.2006.06.001","article-title":"Pathogenesis of Renal Anemia","volume":"26","author":"Nangaku","year":"2006","journal-title":"Semin. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","article-title":"Association of Kidney Function With Anemia","volume":"162","author":"Astor","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.kisu.2017.07.007","article-title":"Complications of chronic kidney disease: Current state, knowledge gaps, and strategy for action","volume":"7","author":"Bello","year":"2017","journal-title":"Kidney Int. Suppl."},{"key":"ref_15","unstructured":"Chauhan, V. (2020, February 22). The 3 Most Common Causes of Chronic Kidney Disease, Verywell Health, Posted July 24, 2019. Available online: https:\/\/www.verywellhealth.com\/common-causes-of-chronic-kidney-disease-2085786."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/kisup.2013.79","article-title":"Risk factors for chronic kidney disease: An update","volume":"3","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pop.2008.01.008","article-title":"Chronic Kidney Disease and Its Complications","volume":"35","author":"Thomas","year":"2008","journal-title":"Prim. Care: Clin. Off. Pr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.amjmed.2008.10.028","article-title":"The Management of Hyperkalemia in Patients with Cardiovascular Disease","volume":"122","author":"Khanna","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_19","first-page":"S182","article-title":"Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update","volume":"37","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"ref_20","unstructured":"WHO Scientific Group (1968). Nutritional Anemias, World Health Organization. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/40707\/WHO_TRS_405.pdf."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/030079904X2763","article-title":"The prevalence of anemia in patients with chronic kidney disease","volume":"20","author":"McClellan","year":"2004","journal-title":"Curr. Med Res. Opin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.seminhematol.2008.06.006","article-title":"Epidemiology of Anemia in Older Adults","volume":"45","author":"Patel","year":"2008","journal-title":"Semin. Hematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1681\/ASN.2004070597","article-title":"Effects of Anemia and Left Ventricular Hypertrophy on Cardiovascular Disease in Patients with Chronic Kidney Disease","volume":"16","author":"Weiner","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney Disease as a Risk Factor for Development of Cardiovascular Disease","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertens."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0025-7753(09)70961-3","article-title":"Anemia en la insuficiencia renal cr\u00f3nica y sus implicaciones cardiovasculares","volume":"132","author":"Cases","year":"2009","journal-title":"Med. Cl\u00ednica"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jamda.2006.09.005","article-title":"Practical Approach to the Diagnosis and Treatment of Anemia Associated With CKD in Elderly","volume":"7","author":"Agarwal","year":"2006","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.ajkd.2005.10.010","article-title":"Serum Carboxymethyllysine Predicts Mortality in Hemodialysis Patients","volume":"47","author":"Wagner","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/ndt\/gfp592","article-title":"Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease","volume":"25","author":"Liabeuf","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.ki.5000115","article-title":"Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients","volume":"69","author":"Bammens","year":"2006","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1681\/ASN.2005020132","article-title":"Serum \u03b2-2 Microglobulin Levels Predict Mortality in Dialysis Patients: Results of the HEMO Study","volume":"17","author":"Cheung","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: Classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/cs0430493","article-title":"Volatile Phenols in Serum of Uraemic Patients","volume":"43","author":"Wengle","year":"1972","journal-title":"Clin. Sci."},{"key":"ref_34","first-page":"96","article-title":"Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis","volume":"124","author":"Niwa","year":"1994","journal-title":"J. Lab. Clin. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000189334","article-title":"Inhibition of the Accumulation of Uremic Toxins in the Blood and Their Precursors in the Feces after Oral Administration of Lebenin\u00ae, a Lactic Acid Bacteria Preparation, to Uremic Patients Undergoing Hemodialysis","volume":"74","author":"Hida","year":"1996","journal-title":"Nephron"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/ki.1994.221","article-title":"Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis","volume":"45","author":"Kabanda","year":"1994","journal-title":"Kidney Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/ndt\/16.5.999","article-title":"Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients","volume":"16","author":"Stein","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ki.1992.318","article-title":"Adequacy of dialysis: A critical analysis","volume":"42","author":"Vanholder","year":"1992","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199309303291404","article-title":"The Urea Reduction Ratio and Serum Albumin Concentration as Predictors of Mortality in Patients Undergoing Hemodialysis","volume":"329","author":"Owen","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1046\/j.1523-1755.2000.07606.x","article-title":"The removal of uremic toxins","volume":"58","author":"Dhondt","year":"2000","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ndt\/15.1.50","article-title":"Intradialytic removal of protein-bound uraemic toxins: Role of solute characteristics and of dialyser membrane","volume":"15","author":"Lesaffer","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/toxins3070911","article-title":"Protein-Bound Uremic Toxins: New Insight from Clinical Studies","volume":"3","author":"Liabeuf","year":"2011","journal-title":"Toxins"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/labinvest.2011.114","article-title":"Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner","volume":"91","author":"Chiang","year":"2011","journal-title":"Lab. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.jrn.2011.10.028","article-title":"Dysregulated Oxygen Metabolism of the Kidney by Uremic Toxins: Review","volume":"22","author":"Chiang","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00467-008-0762-9","article-title":"What is new in uremic toxicity?","volume":"23","author":"Vanholder","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"ref_46","first-page":"1","article-title":"Uremic toxicity of indoxyl sulfate","volume":"72","author":"Niwa","year":"2010","journal-title":"Nagoya J. Med. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1681\/ASN.V1081815","article-title":"Pathophysiologic Effects of Uremic Retention Solutes","volume":"10","author":"Vanholder","year":"1999","journal-title":"JASN"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ndt\/gfr056","article-title":"Warning: The unfortunate end of p-cresol as a uraemic toxin","volume":"26","author":"Vanholder","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/bdd.1834","article-title":"Albumin is the main plasma binding protein for indoxyl sulfate and p -cresyl sulfate: Albumin is main carrier of indoxyl sulfate and p -cresyl sulfate","volume":"34","author":"Viaene","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jcla.20456","article-title":"p-cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease","volume":"25","author":"Lin","year":"2011","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000168716","article-title":"Progression of Glomerular Sclerosis in Experimental Uremic Rats by Administration of Indole, a Precursor of Indoxyl Sulfate","volume":"14","author":"Niwa","year":"1994","journal-title":"Am. J. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Sun, C.-Y., Chang, S.-C., and Wu, M.-S. (2012). Uremic Toxins Induce Kidney Fibrosis by Activating Intrarenal Renin\u2013Angiotensin\u2013Aldosterone System Associated Epithelial-to-Mesenchymal Transition. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034026"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.arcmed.2012.08.002","article-title":"Indoxyl Sulfate Predicts Cardiovascular Disease and Renal Function Deterioration in Advanced Chronic Kidney Disease","volume":"43","author":"Lin","year":"2012","journal-title":"Arch. Med. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","article-title":"The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells","volume":"5","author":"Dou","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","article-title":"Elevation of circulating endothelial microparticles in patients with chronic renal failure","volume":"4","author":"Faure","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ki.2013.133","article-title":"Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway","volume":"84","author":"Gondouin","year":"2013","journal-title":"Kidney Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1681\/ASN.2017030361","article-title":"Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling","volume":"29","author":"Machado","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000098542","article-title":"Indoxyl Sulfate and Atherosclerotic Risk Factors in Hemodialysis Patients","volume":"27","author":"Taki","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1523-1755.2003.00906.x","article-title":"Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-\u03baB and free radical in proximal tubular cells","volume":"63","author":"Motojima","year":"2003","journal-title":"Kidney Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","article-title":"Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?","volume":"31","author":"Lekawanvijit","year":"2010","journal-title":"Eur. Hear. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2012.07.012","article-title":"The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis","volume":"225","author":"Lin","year":"2012","journal-title":"Atheroscler."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1900\/RDS.2010.7.275","article-title":"Increased Levels of Total P-Cresylsulphate and Indoxyl Sulphate are Associated with Coronary Artery Disease in Patients with Diabetic Nephropathy","volume":"7","author":"Chiu","year":"2011","journal-title":"Rev. Diabet. Stud."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Ahmed, M.S.E., Abed, M., Voelkl, J., and Lang, F. (2013). Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate. Bmc Nephrol., 14.","DOI":"10.1186\/1471-2369-14-244"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1253\/circj.CJ-12-0884","article-title":"Indoxyl sulfate counteracts endothelial effects of erythropoietin through suppression of Akt phosphorylation","volume":"77","author":"Adelibieke","year":"2013","journal-title":"Circ. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cyto.2010.03.020","article-title":"Erythropoietin-dependent endothelial proteins: Potential use against erythropoietin resistance","volume":"51","author":"Congote","year":"2010","journal-title":"Cytokine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cyto.2005.01.017","article-title":"Thrombospondin 1, produced by endothelial cells under the action of erythropoietin, stimulates thymidine incorporation into erythroid cells and counteracts the inhibitory action of insulin-like growth factor binding protein","volume":"30","author":"Congote","year":"2005","journal-title":"Cytokine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"C142","DOI":"10.1152\/ajpcell.00172.2015","article-title":"Activation of aryl hydrocarbon receptor mediates suppression of hypoxia-inducible factor-dependent erythropoietin expression by indoxyl sulfate","volume":"310","author":"Asai","year":"2016","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.3390\/toxins7114390","article-title":"Indolic Uremic Solutes Enhance Procoagulant Activity of Red Blood Cells through Phosphatidylserine Exposure and Microparticle Release","volume":"7","author":"Gao","year":"2015","journal-title":"Toxins"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/cdd.2012.93","article-title":"Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm","volume":"20","author":"Lee","year":"2012","journal-title":"Cell Death Differ."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.18632\/oncotarget.26782","article-title":"Correction: The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease","volume":"10","author":"Wu","year":"2019","journal-title":"Oncotarget"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Bataille, S., Pelletier, M., Sall\u00e9e, M., Berland, Y., McKay, N., Duval, A., Gentile, S., Mouelhi, Y., Brunet, P., and Burtey, S. (2017). Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients. Bmc Nephrol., 18.","DOI":"10.1186\/s12882-017-0668-5"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Dias, G.F., Bonan, N.B., Steiner, T.M., Tozoni, S.S., Rodrigues, S.D., Nakao, L.S., Kuntsevich, V., Pecoits-Filho, R., Kotanko, P., and Moreno-Amaral, A.N. (2018). Indoxyl Sulfate, a Uremic Toxin, Stimulates Reactive Oxygen Species Production and Erythrocyte Cell Death Supposedly by an Organic Anion Transporter 2 (OAT2) and NADPH Oxidase Activity-Dependent Pathways. Toxins, 10.","DOI":"10.3390\/toxins10070280"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1744-9987.2006.00370.x","article-title":"Polyamines as an Inhibitor on Erythropoiesis of Hemodialysis Patients by In Vitro Bioassay Using the Fetal Mouse Liver Assay","volume":"10","author":"Yoshida","year":"2006","journal-title":"Ther. Apher. Dial."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ki.1991.88","article-title":"Polyamines in the anemia of end-stage renal disease","volume":"39","author":"Kushner","year":"1991","journal-title":"Kidney Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1172\/JCI110197","article-title":"Identification of Spermine as an Inhibitor of Erythropoiesis in Patients with Chronic Renal Failure","volume":"67","author":"Radtke","year":"1981","journal-title":"J. Clin. Investig."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000350141","article-title":"The Uremic Toxin Acrolein Promotes Suicidal Erythrocyte Death","volume":"37","author":"Ahmed","year":"2013","journal-title":"Kidney Blood Press. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000183038","article-title":"Anemia of Chronic Renal Failure: Inhibition of Erythropoiesis by Uremic Serum","volume":"35","author":"Freedman","year":"1983","journal-title":"Nephron"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1074\/jbc.270.3.1230","article-title":"Purification and Characterization of Hypoxia-inducible Factor","volume":"270","author":"Wang","year":"1995","journal-title":"J. Boil. Chem."},{"key":"ref_82","first-page":"829","article-title":"Erythrocytosis associated with a novel missense mutation in the HIF2A gene","volume":"95","author":"Sutherland","year":"2009","journal-title":"Haematol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMoa073123","article-title":"A Gain-of-Function Mutation in theHIF2AGene in Familial Erythrocytosis","volume":"358","author":"Percy","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood-2004-05-1695","article-title":"HIF-2\u03b1 regulates murine hematopoietic development in an erythropoietin-dependent manner","volume":"105","author":"Scortegagna","year":"2005","journal-title":"Blood"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ki.2009.460","article-title":"Hypoxia-inducible factor-2\u03b1-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization","volume":"77","author":"Paliege","year":"2010","journal-title":"Kidney Int."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1111\/hdi.12567","article-title":"HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism","volume":"21","author":"Haase","year":"2017","journal-title":"Hemodial. Int."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrneph.2015.82","article-title":"Anaemia in kidney disease: Harnessing hypoxia responses for therapy","volume":"11","author":"Koury","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrneph.2010.124","article-title":"The suffocating kidney: Tubulointerstitial hypoxia in end-stage renal disease","volume":"6","author":"Mimura","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MNH.0b013e3283328eed","article-title":"The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease","volume":"19","author":"Tanaka","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1681\/ASN.2010010116","article-title":"Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD","volume":"21","author":"Bernhardt","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1182\/blood-2012-08-449181","article-title":"HIF-1\u03b1 is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2\u03b1\u2013induced excessive erythropoiesis","volume":"121","author":"Franke","year":"2013","journal-title":"Blood"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood-2003-02-0448","article-title":"The HIF family member EPAS1\/HIF-2\u03b1 is required for normal hematopoiesis in mice","volume":"102","author":"Scortegagna","year":"2003","journal-title":"Blood"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1182\/blood-2010-02-270322","article-title":"Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia","volume":"116","author":"Kapitsinou","year":"2010","journal-title":"Blood"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1096\/fj.13-231837","article-title":"Indoxyl sulfate signals for rapid mRNA stabilization of Cbp\/p300-interacting transactivator with Glu\/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia","volume":"27","author":"Tanaka","year":"2013","journal-title":"Faseb J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/sj.leu.2403383","article-title":"Apoptotic mechanisms in the control of erythropoiesis","volume":"18","author":"Testa","year":"2004","journal-title":"Leuk."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020322800101","article-title":"Erythropoietin: Physiology and Pharmacology Update","volume":"228","author":"Fisher","year":"2003","journal-title":"Exp. Boil. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1101\/gad.10.2.154","article-title":"Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis","volume":"10","author":"Lin","year":"1996","journal-title":"Genes Dev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(95)90234-1","article-title":"Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor","volume":"83","author":"Wu","year":"1995","journal-title":"Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1182\/blood-2005-02-0684","article-title":"Core erythropoietin receptor signals for late erythroblast development","volume":"107","author":"Menon","year":"2006","journal-title":"Blood"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tcb.2005.01.007","article-title":"Turning cells red: Signal transduction mediated by erythropoietin","volume":"15","author":"Richmond","year":"2005","journal-title":"Trends Cell Boil."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/excr.1999.4673","article-title":"Signal Transduction in the Erythropoietin Receptor System","volume":"253","author":"Wojchowski","year":"1999","journal-title":"Exp. Cell Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0609.2007.00818.x","article-title":"Erythropoietin after a century of research: Younger than ever","volume":"78","author":"Jelkmann","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Rishi, G., and Subramaniam, V.N. (2017). The relationship between systemic iron homeostasis and erythropoiesis. Biosci. Rep., 37.","DOI":"10.1042\/BSR20170195"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MOH.0000000000000132","article-title":"New insights into iron regulation and erythropoiesis","volume":"22","author":"Kim","year":"2015","journal-title":"Curr. Opin. Hematol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000315102","article-title":"Ceramide in Suicidal Death of Erythrocytes","volume":"26","author":"Lang","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver","volume":"276","author":"Park","year":"2000","journal-title":"J. Boil. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1681\/ASN.2006070802","article-title":"Molecular Control of Iron Transport","volume":"18","author":"Ganz","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-med-050109-142444","article-title":"Hepcidin and Disorders of Iron Metabolism","volume":"62","author":"Ganz","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood-2005-10-4043","article-title":"Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System","volume":"108","author":"Tomosugi","year":"2006","journal-title":"Blood"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/jcla.21634","article-title":"Hepcidin-25 Concentrations Are Markedly Increased in Patients With Chronic Kidney Disease and Are Inversely Correlated With Estimated Glomerular Filtration Rates","volume":"27","author":"Troutt","year":"2013","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Singh, A.K. (2018). Erythropoiesis. Textbook of Nephro-Endocrinology, Elsevier.","DOI":"10.1016\/B978-0-12-803247-3.00012-X"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MOH.0b013e32834521c8","article-title":"Stress erythropoiesis: New signals and new stress progenitor cells","volume":"18","author":"Paulson","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/HS9.0000000000000035","article-title":"Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism","volume":"2","author":"Coffey","year":"2018","journal-title":"HemaSphere"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ndt\/gfx252","article-title":"The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease","volume":"33","author":"Hamano","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1001\/jama.297.15.1713","article-title":"Use of Epoetin in Chronic Renal Failure","volume":"297","author":"Coyne","year":"2007","journal-title":"JAMA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin","volume":"316","author":"Eschbach","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"992","DOI":"10.7326\/0003-4819-111-12-992","article-title":"Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal Disease: Results of a Phase III Multicenter Clinical Trial","volume":"111","author":"Eschbach","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2007.06.008","article-title":"KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target","volume":"50","author":"Levin","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"ref_121","unstructured":"McMurray, J.J., Parfrey, P.S., Adamson, J.W., Aljama, P., Berns, J.S., Bohlius, J., Dr\u00fceke, T.B., Finkelstein, F.O., Fishbane, S., and Ganz, T. (2012). Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int. Supp., 64."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia","volume":"355","author":"Locatelli","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease","volume":"355","author":"Singh","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1525-139X.2007.00420.x","article-title":"Upper Limit of Serum Ferritin: Misinterpretation of the 2006 KDOQI Anemia Guidelines: Upper limit of serum ferritin: Misinterpretation of guidelines","volume":"21","author":"Fishbane","year":"2008","journal-title":"Semin. Dial."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.ajkd.2008.12.040","article-title":"Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients","volume":"53","author":"Lee","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrneph.2010.139","article-title":"Iron supplementation to treat anemia in patients with chronic kidney disease","volume":"6","author":"Besarab","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0272-6386(99)70103-4","article-title":"A study of parenteral iron regimens in hemodialysis patients","volume":"34","author":"Besarab","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1681\/ASN.V113530","article-title":"Optimization of Epoetin Therapy with Intravenous Iron Therapy in Hemodialysis Patients","volume":"11","author":"Besarab","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1182\/blood-2007-02-073254","article-title":"HIF\u2013prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques","volume":"110","author":"Hsieh","year":"2007","journal-title":"Blood"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(06)69120-4","article-title":"Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia","volume":"368","author":"MacDougall","year":"2006","journal-title":"Lancet"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1813599","article-title":"Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.kint.2017.02.035","article-title":"Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease","volume":"92","author":"Sugahara","year":"2017","journal-title":"Kidney Int."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000186222","article-title":"Inhibitory Effect of Oral Sorbent on Accumulation of Albumin-Bound Indoxyl Sulfate in Serum of Experimental Uremic Rats","volume":"57","author":"Niwa","year":"1991","journal-title":"Nephron"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ndt\/6.2.105","article-title":"Oral Sorbent Suppresses Accumulation of Albumin-Bound Indoxyl Sulphate in Serum of Haemodialysis Patients","volume":"6","author":"Niwa","year":"1991","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000168447","article-title":"Suppressed Serum and Urine Levels of Indoxyl Sulfate by Oral Sorbent in Experimental Uremic Rats","volume":"12","author":"Niwa","year":"1992","journal-title":"Am. J. Nephrol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/ndt\/15.11.1773","article-title":"An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-\u03b21 in uraemic rat kidneys","volume":"15","author":"Miyazaki","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/ndt\/gfu061","article-title":"Oral adsorbent AST-120 potentiates the effect of erythropoietin-stimulating agents on Stage 5 chronic kidney disease patients: A randomized crossover study","volume":"29","author":"Wu","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/ckj\/sfx100","article-title":"Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease","volume":"10","author":"Roger","year":"2017","journal-title":"Clin. Kidney J."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1053\/j.ajkd.2016.12.011","article-title":"Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD","volume":"69","author":"Gupta","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1901713","article-title":"Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/9\/2039\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:07:20Z","timestamp":1760177240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/9\/2039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,6]]},"references-count":140,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["cells9092039"],"URL":"https:\/\/doi.org\/10.3390\/cells9092039","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,6]]}}}